
»ØÊ×£ºÉÏÖÜ3¼Ò¹«Ë¾Íê³ÉÉÏÊУ¬£¬£¬£¬£¬£¬¹²Ä¼×ÊÔ¼2200ÍòÃÀÔª¡£¡£¡£¡£
½ðÉúÓÎÀÖ (GDHG)ÒÔÿ¹É4ÃÀÔªµÄ¼ÛÇ®£¬£¬£¬£¬£¬£¬¿¯ÐÐÁË175Íò¹É£¬£¬£¬£¬£¬£¬ÕÙļ×ʽð700ÍòÃÀÔª¡£¡£¡£¡£VCI Global (VCIG)ÒÔÿ¹É4ÃÀÔªµÄ¼ÛÇ®£¬£¬£¬£¬£¬£¬¿¯ÐÐÁË128Íò¹É£¬£¬£¬£¬£¬£¬ÕÙļ×ʽð512ÍòÃÀÔª¡£¡£¡£¡£CytoMed Therapeutics (GDTC)ÒÔÿ¹É4ÃÀÔªµÄ¼ÛÇ®£¬£¬£¬£¬£¬£¬¿¯ÐÐÁË241Íò¹É£¬£¬£¬£¬£¬£¬ÕÙļ×ʽð965ÍòÃÀÔª¡£¡£¡£¡£
±¾ÖÜ£¬£¬£¬£¬£¬£¬ÓÐ2¼Ò¹«Ë¾ÍýÏëÉÏÊУ¬£¬£¬£¬£¬£¬¾ùΪÖÐÆó£¬£¬£¬£¬£¬£¬°üÀ¨´Ëǰ¶à´ÎÍÆ³ÙµÄÓÅÆ·³µ¡£¡£¡£¡£

1¡¢µç³ØÌæ»»Õ¾¿ª·¢ÉÌ¡ª¡ªÓÅÆ·³µ
ÍýÏëÉÏÊÐʱ¼ä£º2023Äê4ÔÂ19ÈÕ
ÉúÒâËù£ºNASDAQ
¹ÉƱ´úÂ룺UCAR
ÓÅÆ·³µ×î³õÊÇÒ»¼ÒÆû³µ²É¹ºÐ§ÀÍÌṩÉÌ£¬£¬£¬£¬£¬£¬ÔÚÆû³µÅú·¢É̺ÍÂò¼ÒÖ®¼äÊðÀíÆû³µÏúÊÛ£¬£¬£¬£¬£¬£¬°üÀ¨ÖÐСÐÍÆû³µ¾ÏúÉÌ¡¢Ð¡ÎÒ˽¼Ò¿Í»§(Ö÷ҪλÓÚÈý¡¢ËÄÏß¶¼»á)¡£¡£¡£¡£2021Ä꣬£¬£¬£¬£¬£¬¸Ã¹«Ë¾ÒÔUOTTAÆ·ÅÆ¿ª·¢ÆäרÓеÄÖÇÄÜ»»µç¼¼Êõ£¬£¬£¬£¬£¬£¬ÍƳö5¿î»»µç³µÐÍ£¬£¬£¬£¬£¬£¬¿ÉÆÕ±éÓ¦ÓÃÓÚ¿óɽ¡¢ÄÜÔ´¡¢½»Í¨¡¢¿Ú°¶¡¢¶¼»áÎïÁ÷µÈÐÐÒµ¡£¡£¡£¡£
ļ×ʹæÄ£
¸Ã¹«Ë¾ÍýÏëÒÔÿ¹É6ÖÁ8ÃÀÔªµÄ¼ÛÇ®£¬£¬£¬£¬£¬£¬¿¯ÐÐ250Íò¹É£¬£¬£¬£¬£¬£¬×î¸ßļ×ÊÔ¼2000ÍòÃÀÔª¡£¡£¡£¡£
²ÆÎñÊý¾Ý
¾ÝÕйÉÊéÏÔʾ£¬£¬£¬£¬£¬£¬ÔÚÒÑÍùµÄ2020Äê¡¢2021Äê¸Ã¹«Ë¾µÄÓªÊÕ»®·ÖΪ146.40ÍòÈËÃñ±Ò¡¢801.00ÍòÈËÃñ±Ò£¬£¬£¬£¬£¬£¬Õâʱ´úÏìÓ¦µÄ¾»ÀûÈó»®·ÖΪ-653.00ÍòÈËÃñ±Ò¡¢-4906.40ÍòÈËÃñ±Ò¡£¡£¡£¡£
2022ÄêǰÁù¸öÔ£¬£¬£¬£¬£¬£¬¸Ã¹«Ë¾µÄÓªÊÕΪ427.70ÍòÈËÃñ±Ò£¬£¬£¬£¬£¬£¬ÉÏÄêͬÆÚΪ59.80ÍòÈËÃñ±Ò£¬£¬£¬£¬£¬£¬Õâʱ´úÏìÓ¦µÄ¾»ÀûÈó»®·ÖΪ-1298.60ÍòÈËÃñ±Ò¡¢-1664.50ÍòÈËÃñ±Ò¡£¡£¡£¡£

2¡¢ÐÞ½¨³Ð°üÉÌ¡ª¡ªºêÀûÓªÔìÆæ·¢28
ÍýÏëÉÏÊÐʱ¼ä£º2023Äê4ÔÂ20ÈÕ
ÉúÒâËù£ºNASDAQ
¹ÉƱ´úÂ룺WLGS
ºêÀûÓªÔìÆæ·¢28×ܲ¿Î»ÓÚÏã¸Û£¬£¬£¬£¬£¬£¬ÊÇÒ»¼ÒÐÞ½¨Ö÷³Ð°üÉ̺ͷְüÉÌ£¬£¬£¬£¬£¬£¬ÎªÉÌÒµºÍסլ¿ª·¢ÉÌÒÔ¼°ÍâµØÆóÒµµÈ˽ÈËÐÞ½¨¿Í»§ÌṩÆÕ±éµÄ´óÐÍÏÖ³¡Ê©¹¤Ð§ÀÍ¡£¡£¡£¡£
ļ×ʹæÄ£
¸Ã¹«Ë¾ÍýÏëÒÔÿ¹É5ÃÀÔªµÄ¼ÛÇ®£¬£¬£¬£¬£¬£¬¿¯ÐÐ160Íò¹É£¬£¬£¬£¬£¬£¬Ô¤¼ÆÄ¼×ÊÔ¼800ÍòÃÀÔª¡£¡£¡£¡£
²ÆÎñÊý¾Ý
¾ÝÕйÉÊéÏÔʾ£¬£¬£¬£¬£¬£¬ÔÚÒÑÍùµÄ2020Äê¡¢2021Äê¸Ã¹«Ë¾µÄÓªÊÕ»®·ÖΪ407.43ÍòÃÀÔª¡¢413.51ÍòÃÀÔª£¬£¬£¬£¬£¬£¬Õâʱ´úÏìÓ¦µÄ¾»ÀûÈó»®·ÖΪ27.80ÍòÃÀÔª¡¢-35.47ÍòÃÀÔª¡£¡£¡£¡£
2022ÄêǰÁù¸öÔ£¬£¬£¬£¬£¬£¬¸Ã¹«Ë¾µÄÓªÊÕΪ125.01ÍòÃÀÔª£¬£¬£¬£¬£¬£¬ÉÏÄêͬÆÚΪ200.07ÍòÃÀÔª£¬£¬£¬£¬£¬£¬Õâʱ´úÏìÓ¦µÄ¾»ÀûÈó»®·ÖΪ-38.35ÍòÃÀÔª¡¢11.72ÍòÃÀÔª¡£¡£¡£¡£
Ææ·¢28
Ææ·¢28£¨ÃÀ¹úÉÏÊÐ¹ÉÆ±´úÂëWFHG£©£¬£¬£¬£¬£¬£¬ÊÇÒ»¼ÒרҵÐÖúÆóÒµÔÚº£ÄÚÍâÉÏÊÐÈÚ×ʽøÈë×ÊÔ´Êг¡µÄÈ«·½Î»×ÊÔ´ÔË×÷ЧÀÍ»ú¹¹¡£¡£¡£¡£º¬Ïòµ¼ÉÏÊС¢¶¥²ãÉè¼Æ¡¢ÊÐÖµ¹ÜÀí¡¢Í¶×ÊÈÚ×Ê¡¢²¢¹ºÖØ×éµÈ£¬£¬£¬£¬£¬£¬Ææ·¢28¶À´´IAPOÉÏÊÐģʽ£¬£¬£¬£¬£¬£¬Æ¾Ö¤ÆóÒµµÄÏÖÕæÏàÐΣ¬£¬£¬£¬£¬£¬ÍýÏë×îºÏÊʵÄÉÏÊз¾¶£¬£¬£¬£¬£¬£¬Ìá¸ßÆóÒµÉÏÊÐÀÖ³ÉÂÊ¡£¡£¡£¡£


Ææ·¢28Ïà¹ØµÄ»¥Áª¼Ò»ù½ð£¬£¬£¬£¬£¬£¬ÍŶÓ×Ô99Äê´ÓÊ»ù½ð¹ÜÀíÖÁ½ñ£¬£¬£¬£¬£¬£¬ÓµÓлù½ð¹ÜÀíÅÆÕÕP1070824£¬£¬£¬£¬£¬£¬Ö÷Óª¡°¹ÜÀí¹ÉȨͶ×Ê»ù½ð¡¢Õþ¸®Ö¸µ¼»ù½ð¡¢¹¤ÒµÍ¶×Ê»ù½ð¡¢´´ÒµÍ¶×Ê»ù½ð£¬£¬£¬£¬£¬£¬×ʲú¹ÜÀí¡¢Í¶×ʹÜÀí£¬£¬£¬£¬£¬£¬´´ÒµÍ¶×Ê¡±µÈÓªÒµ¡£¡£¡£¡£±¾»ù½ðΪ˽ļ¹ÉȨ»ù½ð£¬£¬£¬£¬£¬£¬ÔÚ¹ÜÀíʵ½É»ù½ð¹æÄ£Áè¼Ý200ÒÚÔª£¬£¬£¬£¬£¬£¬ÀۼƹÜÀíʵ½É¹æÄ£Áè¼Ý634.896ÒÚÔª¡£¡£¡£¡£ÒÑÀֳɷõ»¯Í˳ö52¼ÒÆóÒµ£¬£¬£¬£¬£¬£¬²¢Ö±½ÓͶ×ÊÔÚº£ÄÚÖ÷°å¡¢Ïã¸ÛÖ÷°å¡¢ÃÀ¹úÄÉ˹´ï¿ËµÈÀÖ³ÉIPOÉÏÊÐ24¼Ò¿Æ¼¼ÐÍÆóÒµ£¬£¬£¬£¬£¬£¬ÈçÉе¹ɷݡ¢°²¿ÆÉúÎï¡¢»ª¹â¹É·Ý¡¢¼ªöοƼ¼ºÍ°®¿µ¹É·ÝµÈ£¬£¬£¬£¬£¬£¬Í¨¹ý×ÊÔ´ÔËÓªÔöֵЧÀÍÍÆ¶¯Ïà¹ØÆóÒµ³ÉΪ¹ú¼Ê£¨»òº£ÄÚ£©Ï¸·ÖÐÐÒµÁúÍ·£¬£¬£¬£¬£¬£¬ÆäÖÐÁ½¼ÒÔø±»ÁÐÈë¹þ·ð´óѧºÍÇ廪´óѧ½Ìѧ°¸Àý¡£¡£¡£¡£

Ææ·¢28¿Ø¹ÉµÄÉϺ£¿£¿£¿£¿Ø±¾ÆóÒµ¹ÜÀíÓÐÏÞ¹«Ë¾ÎªÉÏÊÐÅäÌ×ЧÀÍ»ú¹¹£¬£¬£¬£¬£¬£¬Ö÷Ӫ֪ʶ²úȨ³ö×ÊÓë×ÊÔ´ÔË×÷ÓªÒµ£¬£¬£¬£¬£¬£¬°ïÆóÒµ°ÑÎÞÐÎ×ʲúת»¯ÎªÓмÛÖµ×ʲú£¬£¬£¬£¬£¬£¬²¢³ÉΪʵ½É×ÊÔ´£¬£¬£¬£¬£¬£¬ÈÏÁÐ×ÊÔ´¹«»ý£¬£¬£¬£¬£¬£¬Ìá¸ßÆóÒµ¾»×ʲú£¬£¬£¬£¬£¬£¬¸ÄÉÆ¸÷×ÊÔ´±ÈÖØ£¬£¬£¬£¬£¬£¬ÐÖúÆóÒµ¹¤ÒµÉý¼¶¡£¡£¡£¡£Ææ·¢28ÔÚÃÀ¹ú¡¢Ó¢¹ú¡¢ÉϺ£¡¢±±¾©¡¢ÉîÛÚ¡¢Î÷°²¡¢ºþ±±¡¢½ËÕ¡¢ËÄ´¨µÈµØÉèÁ¢°ì¹«ÊÒ¼°×ÊÔ´ÖÐÐÄ£¬£¬£¬£¬£¬£¬»ã¾ÛÈ«Çò¸÷ÐÐÒµ¾«Ó¢Ç̳þ£¬£¬£¬£¬£¬£¬¾«½ø×¨Òµ¡¢Èº¼¯×ÊÔ´£¬£¬£¬£¬£¬£¬ÎªÆóÒµ´´Á¢¸ü¸ß¼ÛÖµ£¬£¬£¬£¬£¬£¬ÖúÁ¦ÆóÒµÈÚ×ÊÉÏÊУ¬£¬£¬£¬£¬£¬³ÉΪ¹ú¼Ê×ÅÃû´óÐÍÆæ·¢28£¡
ȪԴ: ÊÀ½ç½ð¿ØÃ½×ʲ¿ÕûºÏ±à¼
? ÃâÔðÉùÃ÷£º±¾Æ½Ì¨ÄÚÈݲ¿·ÖȪԴÓÚÍøÂ磬£¬£¬£¬£¬£¬ÐÅÏ¢½ö¹©²Î¿¼£¬£¬£¬£¬£¬£¬±¾Æ½Ì¨²»¼ç¸ºÔðÈΡ£¡£¡£¡£ÈôÊÇÇÖÕ¼ÄúµÄÈ¨ÒæÇëʵʱ¼û¸æÎÒÃÇ£¬£¬£¬£¬£¬£¬ÎÒÃǽ«ÓÚµÚһʱ¼äɾ³ý¡£¡£¡£¡£